Slide 1: Second Quarter 2026 Earnings Presentation
SECOND QUARTER 2026 EARNINGS PRESENTATION July 29, 2026
Slide 2: Use of non-GAAP financial measures and forward-looking statements
Use of non-GAAP financial measures: This presentation includes certain non‐GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. Reconciliations of non‐GAAP financial measures to GAAP financial measures are provided within the Appendix to this presentation. In
Slide 3: Agenda
AGENDA 1 Recent Highlights 2 Consolidated Financial Performance 3 Segment Performance 4 Outlook 5 Key Takeaways 6 Q&A 3
Slide 4: Recent Highlights
RECENT HIGHLIGHTS Continued execution of portfolio strategy and operational excellence Completed sale of Road Markings product line in April; sales process for Advanced Polymer Technologies in an advanced stage, demonstrating continued execution of portfolio optimization strategy Repurchased $35 mil
Slide 5: Second Quarter (Q2) Consolidated Financial Performance
SECOND QUARTER (Q2) CONSOLIDATED FINANCIAL PERFORMANCE Q2 Financials (1) Performance Highlights Q2 Q2 vs PY Net sales declined driven by sale of Road Markings product line on April $ in millions except percentage and per share data 2026 2025 ∆% 15, 2026. Excluding Road Markings, net sales in all seg
Slide 6: Q2 2026 Financial Metrics and Highlights
Q2 2026 FINANCIAL METRICS AND HIGHLIGHTS Net Debt Ratio(1) and Trailing Twelve Months (TTM) Total Adj. Free Cash Flow(1) EBITDA(1) In millions (except share and per share data) $2.52 Net Debt Ratio TTM Total Company Adj. EBITDA 3.2 450 3.0 $1.82 3.0 400 $1.57 2.8 2.7 350 2.6 2.6 89 2.6 2.5 67 300 61
Slide 7: Performance Materials
PERFORMANCE MATERIALS $ % $ IN MILLIONS Q2 2026 Q2 2025 VS. PRIOR VS. PRIOR Performance Highlights YEAR YEAR Net Sales 160.6 153.9 6.7 4.4% Sales growth was driven by higher volumes and favorable mix as Segment EBITDA 86.1 81.0 5.1 6.3% consumer preferences continued to shift from battery electric S
Slide 8: Pavement Technologies
PAVEMENT TECHNOLOGIES Q2 Q2 $ % Performance Highlights(2) $ IN MILLIONS VS. PRIOR VS. PRIOR 2026 2025 YEAR YEAR Net Sales 104.2 134.3 (30.1) (22.4)% Sales decline driven by the April 15, 2026, sale of the Road Markings Pavement Technologies 99.9 96.9 3.0 3.1% product line. Excluding Road Markings, s
Slide 9: Advanced Polymer Technologies
ADVANCED POLYMER TECHNOLOGIES $ % $ IN MILLIONS Q2 2026 Q2 2025 VS. PRIOR VS. PRIOR Performance Highlights YEAR YEAR Net Sales 49.3 43.3 6.0 13.9% Sales increase was driven by pricing surcharges, a favorable mix Segment EBITDA 11.2 2.0 9.2 460% toward higher-value derivative products and competitor
Slide 10: 2026 Full Year Outlook
2026 FULL YEAR OUTLOOK Strong first-half execution and results support higher guidance 2026 Current Outlook vs. Prior Prior Current Second Half Outlook Assumptions Financial Metric Full Year Outlook Full Year Outlook ▪ Second-half Adjusted EBITDA expected to be lower than first half, driven primaril
Slide 11: Key Takeaways
KEY TAKEAWAYS Portfolio transformation nearing completion; continues to improve business quality and focus Core businesses continue to demonstrate resilient margins and cash generation Raised Adjusted EBITDA and EPS guidance as first half results support confidence in full year outlook Disciplined c
Slide 12: Thank you for your interest in Ingevity
FOR MORE INFORMATION Investors Mickey Walsh (843) 740 - 2002 Media Caroline Monahan (843) 740 - 2068 Thank you for your interest in Ingevity. 12
Slide 13: Appendix
APPENDIX 13
Slide 14: Non-GAAP financial measures
Ingevity has presented certain financial measures, defined below, which have not been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and has provided a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP on the follo
Slide 15: Adjusted Earnings and Diluted Adjusted Earnings per Share Reconciliation
Adjusted Earnings and Diluted Adjusted Earnings per Share Reconciliation (GAAP to Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except per data (unaudited) 2026 2025 2026 2025 Net income (loss) from continuing operations (GAAP) $ 39.8 $ (141.4) $ 63.2 $ (112.3) Restruc
Slide 16: Adjusted Earnings and Diluted Adjusted Earnings per Share Reconciliation (notes)
Adjusted Earnings and Diluted Adjusted Earnings per Share Reconciliation (GAAP to Non-GAAP) (3) The gain relates to the sale of our former Performance Chemicals' road markings product line on April 15, 2026. (4) For information on our litigation charges please refer to Note 13, Commitments and Conti
Slide 17: Restructuring and other charges
Restructuring and other (income) charges Three Months Ended June 30, Six Months Ended June 30, In millions 2026 2025 2026 2025 Work force reductions and other $ 1.3 $ 6.5 $ 1.0 $ 7.7 Performance Chemicals repositioning 0.4 0.7 1.2 1.4 Restructuring charges (1) $ 1.7 $ 7.2 $ 2.2 $ 9.1 Other (income)
Slide 18: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (GAAP to Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2026 2025 2026 2025 Net income (loss) from continuing operations (GAAP) $ 39.8 $ (141.4) $ 63.2 $ (112.3) Provision (benefit) for income taxes 10.9 4.8
Slide 19: Adjusted Gross Profit Reconciliation
Adjusted Gross Profit Reconciliation (GAAP to Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2026 2025 2026 2025 Gross Profit (GAAP) $ 139.0 $ 127.8 $ 255.4 $ 239.7 Plus: Depreciation and amortization 15.2 15.1 30.5 30.0 Adjusted gross pro
Slide 20: Adjusted SG&A Reconciliation
Adjusted SG&A Reconciliation (GAAP to Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2026 2025 2026 2025 SG&A (GAAP) $ 39.0 $ 43.6 $ 79.7 $ 85.5 Research and technical expenses (GAAP) 6.1 7.0 12.8 14.0 Total SG&A (GAAP) $ 45.1 $ 50.6 $ 92.
Slide 21: Adjusted Other Income Expense Reconciliations
Adjusted Other (income) expense, net Reconciliations (GAAP to Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions, except percentages (unaudited) 2026 2025 2026 2025 Other (income) expense, net (GAAP) $ (4.8) $ 4.2 $ 17.6 $ 8.3 Less: Gain on sale of strategic investment — 2.5
Slide 22: Free Cash Flow Calculation
Free Cash Flow Calculation (GAAP to Non-GAAP) Three Months Ended June 30, Six Months Ended June 30, In millions (unaudited) 2026 2025 2026 2025 Cash Flow from Operations (GAAP) $ (13.8) $ 79.0 $ (15.8) $ 104.4 Less: Capital Expenditures (GAAP) 10.3 12.2 20.6 22.2 Less: Litigation Settlement (1) (113
Slide 23: Net Debt to Adjusted EBITDA Ratio Calculation
Net Debt to Adjusted EBITDA Ratio Calculation (Non-GAAP) In millions, except ratios (unaudited) June 30, 2026 Notes payable and current maturities of long-term debt $ 144.0 Long-term debt including finance lease obligations 1,056.2 Debt issuance costs 2.6 Total Debt $ 1,202.8 Less: Cash and cash equ
Slide 24: Net Sales Comparison
Net Sales Comparison Ingevity Continuing Operations Change vs prior year In millions Prior year Net sales Volume Price/Mix Currency effect Current year Net sales Three months ended June 30, 2026 vs. 2025 $ 331.5 (28.2) 10.0 0.8 $ 314.1 Six months ended June 30, 2026 vs. 2025 $ 579.4 (27.8) 16.5 4.0